Barts and The London School of Medicine and Dentistry offers international excellence in research and teaching.
We serve a population of unrivalled diversity in east London and the wider Thames Gateway, with a high prevalence of cancer, diabetes, adult and childhood obesity, heart disease, chronic lung diseases, HIV, and oral disease.
Through partnership with our linked hospitals, notably Barts and The London NHS Trust, the School’s research and teaching is informed by a wide ranging and stimulating clinical environment.
Over £100 million has been invested in creating state of the art facilities in Whitechapel and West Smithfield to make East London a place which attracts world-class researchers.
Recent research highlights include:
- identifying susceptibility genes for complex diseases such as hypertension (Mark Caufield, Patricia Munroe), diabetes (Graham Hitman), and coeliac disease (David van Heel);
- the link between air pollution and lung disease in children (Jonathan Grigg);
- new treatments for multiple sclerosis (Gavin Giovannoni)
- identifying the genes responsible for premature ageing in children (Inderjeet Dokal);
- identifying the critical role for PI3kinase alpha in blood vessel formation (Bart Vanhaesebroeck);
- showing that some anti-cancer drugs at low doses promote tumor growth (Kairbaan Hodivala-Dilke);
- and demonstrating that cervical screening has a huge impact in older women but has no effect in younger women (Peter Sasieni, Jack Cuzick).
Barts and The London School of Medicine and Dentistry has also shown the largest increase in research funding in the last five years in the UK.
The School has the highest amount of bluechip charitable income in the UK, and our research spend in 2008-9 of £41.5 million represents a 20 per cent year-on-year increase, the highest in the UK, and moves us to 7th overall.
If calculated in terms of numbers of staff, the school ranks third nationally.
Our current portfolio of 1070 awards totals over £259 million, including £24 million from MRC since 2007, seven programme grants from Wellcome Trust, and 12 programme grants from Cancer Research UK.
Since 2006, nationwide, we have been awarded the largest number of training fellowships by the MRC. Among our senior investigators, 90 per cent have at least one paper with greater than 100 citations and 14 of our senior researchers have, in total, an astonishing 309 papers with greater than 100 citations and individual “H factors” between 50 and 81.
The School’s translational research strength has been recognised by, amongst others, the award of a NIHR Biomedical Research Unit in Cardiovascular Disease, with a £5.4 million grant awarded in 2008 to Barts and The London School of Medicine and Dentistry, and Barts and The London NHS Trust.
Since 2006 we have appointed 26 new professors and 23 lecturers/senior lecturers.